TD Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $185K | Hold |
1,148
| – | – | 0.02% | 126 |
|
|
2025
Q1 | $195K | Hold |
1,148
| – | – | 0.02% | 112 |
|
|
2024
Q4 | $191K | Buy |
1,148
+1
| +0.1% | +$166 | 0.02% | 110 |
|
|
2024
Q3 | $197K | Buy |
1,147
+6
| +0.5% | +$1.03K | 0.02% | 111 |
|
|
2024
Q2 | $176K | Buy |
1,141
+69
| +6% | +$10.6K | 0.02% | 110 |
|
|
2024
Q1 | $165K | Buy |
1,072
+727
| +211% | +$112K | 0.02% | 116 |
|
|
2023
Q4 | $54.5K | Hold |
345
| – | – | 0.01% | 173 |
|
|
2023
Q3 | $50.5K | Buy |
345
+249
| +259% | +$36.4K | 0.01% | 170 |
|
|
2023
Q2 | $14.7K | Buy |
96
+46
| +92% | +$7.04K | ﹤0.01% | 254 |
|
|
2023
Q1 | $7.75K | Hold |
50
| – | – | ﹤0.01% | 285 |
|
|
2022
Q4 | $7.71K | Hold |
50
| – | – | ﹤0.01% | 264 |
|
|
2022
Q3 | $7K | Buy |
+50
| New | +$7K | ﹤0.01% | 255 |
|